President & CEO

Sr. Vice President, Product Development and Chief Marketing Officer at Surmodics

FTC Challenges GTCR’s $627M Deal for Surmodics

Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance

Surmodics reports Q3 EPS (37c), consensus (19c)

Surmodics raises FY25 EPS view to (35c)-(20c) from (62c)-(42c)

Senior Field Clinical Specialist

Surmodics is pursuing highly differentiated medical devices aimed at addressing unmet clinical needs. The Senior Field Clinical Specialist (SFCS) will utilize clinical and technical expertise to train healthcare professionals, establish practice standards, and gather product feedback to inform product development.

Sign up with Google

Sign in with Google